Sign in
4

Changes in Ownership

Verastem, Inc. Filed Acc 0001104659-18-001513

Options or other derivatives

  • Chief Medical Officer acquired 12,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Le NgocDiep T. MD, PhD Chief Medical Officer 2018-01-05 Grant or award · Stock Option (Right to Buy) +12,500 12,500 D: show line 1 in the form
Loading xslF345X03/a4.xml…